Clinical trial
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small…
NCT00201682 · John Byrd, Other · Completed
Key facts
| NCT number | NCT00201682 |
|---|---|
| Title | Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma |
| Official title | Phase I/II Study of Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma |
| Lead sponsor | John Byrd, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma |
| Intervention type | Drug |
| Interventions | Etanercept, Rituximab |
| Enrollment | 36 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: